TallyHQ
github
Client · LDA

PFIZER INC.

10 filings 23 bills mentioned 1 registrants 5 quarters ~$31,500,000 reported
Client ID
138225

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

S 832
EPIC Act of 2025
HCRMMM
7
HR 2214
DRUG Act
HCR
6
HR 5256
340B ACCESS Act
HCRMMM
5
S 864
HELP Copays Act
HCRMMM
4
S 882
Patients Before Middlemen Act
HCRMMM
4
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
HCR
4
S 526
Pharmacy Benefit Manager Transparency Act of 2025
HCRMMM
4
HR 946
ORPHAN Cures Act
HCRMMM
4
HR 2450
Prescription Drug Transparency and Affordability Act
HCRMMM
3
S 2903
Safe Step Act
HCR
3
HR 4317
PBM Reform Act of 2025
HCR
3
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
BUDHCR
3
S 1702
Access to Prescription Digital Therapeutics Act of 2025
MMM
3
HR 5509
Safe Step Act
HCR
3
S 1053
FIGHT China Act of 2025
HCR
2
HR 4581
340B PATIENTS Act of 2025
HCRMMM
2
S 2296
National Defense Authorization Act for Fiscal Year 2026
HCR
2
S 3510
Biosimilar Inspection Modernization Act of 2025
HCR
1
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
BUDTAX
1
HR 2213
Medical Supply Chain Resiliency Act
TRD
1
HR 7837
Most Favored Patient Act of 2026
HCR
1
S 1040
Drug Competition Enhancement Act
HCR
1
S 527
Prescription Pricing for the People Act of 2025
HCRMMM
1

Registrants

Lobbying firms that filed on behalf of this client.

PFIZER INC. 10

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.